Low baseline DLCOcor | 1.25 (1.06–1.48) | 0.008 | 1.29 (1.08–1.55) | 0.005 |
Native lung disease | | | | |
COPD | 1.18 (0.91–1.54) | 0.21 | 1.27 (0.97–1.67) | 0.09 |
Cystic fibrosis | 1.09 (0.83–1.44) | 0.52 | 1.06 (0.80–1.40) | 0.70 |
Interstitial lung disease | 0.84 (0.64–1.10) | 0.20 | 0.96 (0.74–1.26) | 0.78 |
Other | Reference | | Reference | |
Sex matching (recipient/donor) | | | | |
F/M | 1.07 (0.79–1.45) | 0.65 | 1.16 (0.88–1.53) | 0.28 |
M/F | 0.97 (0.73–1.29) | 0.86 | 0.98 (0.75–1.29) | 0.90 |
M/M | 1.20 (0.97–1.49) | 0.09 | 1.24 (1.01–1.52) | 0.04 |
F/F | Reference | | Reference | |
CMV serostatus (donor/recipient) | | | | |
D+/R− | 1.52 (1.15–2.01) | 0.003 | 1.61 (1.24–2.08) | <0.001 |
R+ | 1.35 (1.08–1.70) | 0.001 | 1.45 (1.16–1.80) | 0.001 |
D−/R− | Reference | | Reference | |
Era of transplant | | | | |
2010–2018 | 0.95 (0.79–1.15) | 0.62 | 0.93 (0.79–1.11) | 0.44 |
1998–2009 | Reference | | Reference | |
Recipient age (per 5-unit change) | 0.99 (0.96–1.02) | 0.53 | 0.96 (0.92–1.00) | 0.03 |
Donor age (per 5-unit change) | 1.03 (1.00–1.06) | 0.04 | 1.03 (1.01–1.06) | 0.01 |